Alector, Inc. (ALEC) vs CAMP4 Therapeutics Corporation (CAMP)

Alector, Inc. and CAMP4 Therapeutics Corporation are both Biotechnology companies. Alector, Inc. and CAMP4 Therapeutics Corporation are of similar size ($216.5M and $213.3M). Alector, Inc. has the higher net margin (−850.1% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Alector, Inc. leads on 10 and CAMP4 Therapeutics Corporation on 3.

Valuation

Metric ALEC CAMP Biotechnology median
P/E n/m n/m 8.42
P/S 15.32 47.40 10.01
P/B n/m n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 4.17 26.75 9.41
Earnings yield (57.59%) (67.25%) (31.85%)
Free cash flow yield (74.56%) (14.35%) (24.58%)

Profitability

Metric ALEC CAMP Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (912.40%) (1,254.22%) 0.00%
Net margin (850.13%) (2,543.74%) 0.00%
Free cash flow margin (1,142.55%) (680.36%) 0.00%
Return on equity (385.11%) (545.85%) (56.36%)
Return on assets (42.15%) (148.23%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC CAMP Biotechnology median
Revenue growth (TTM) (82.91%) — 6.02%
EPS growth (last fiscal year) (13.01%) 76.00% 30.26%
Revenue growth, 5-year CAGR (0.05%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALEC CAMP Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 4.70 4.72
Net debt to EBITDA 1.61 2.18 0.96

Dividend

Metric ALEC CAMP Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALEC CAMP Biotechnology median
Market cap 213.27m 216.50m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack